 |
| The battle against methamphetamine pills - seen
here in a Thai police station in 2013 - is being waged across South East Asia |
A Buddhist monk arrested in Myanmar has been linked to
more than four million methamphetamine pills hidden in a monastery, police say.
The monk was first stopped in Rakhine state with 400,000
tablets in his car.
No value has been placed on the hauls, although in 2015
the UN estimated the retail price of a methamphetamine tablet was about $2 -
making the latest consignment worth about $9.2m (£7.3m).
Myanmar has emerged as a top producer of illegal drugs in
recent years.
The senior monk, named only as Arsara, was arrested after
police discovered the first consignment of tablets in his car as he was driving
to the town of Maungdaw bordering Bangladesh.
The second batch in the monastery was found after he was
arrested.
Arsara is well known among the Buddhist community in
Maungdaw, The Irrawaddy reported, and had been a leading monk at the town's
Baho monastery.
Myanmar is notorious for producing vast quantities of
methamphetamines, opium and cannabis, with drug trafficking a particular
problem in Rakhine state.
Myanmar's illicit drug trade has flourished because of
its mountainous land and porous borders.
 |
| The authorities often stage a bonfire of seized
narcotics such as this blaze in June 2015 |
Local reports cited by The Irrawaddy say that in late
September 2016 police in Maungdaw carried out two huge drug hauls, raking in
more than 15 million amphetamine tablets from the compound of a construction
company.
Police in Yangon seized methamphetamine tablets with an
estimated value of more than $100m (£64m) in an abandoned truck in 2015.
http://www.bbc.co.uk/news/world-asia-33695748
A UN Office on Drugs and Crime report in 2015 says that methamphetamine continues to dominate the
synthetic drugs market in East and South-East Asia and is mainly available in
two forms: methamphetamine tablets and crystalline methamphetamine. https://www.unodc.org/documents/southeastasiaandpacific/Publications/2015/drugs/ATS_2015_Report_web.pdf